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Abstract
Depending on their interaction with intracellular proteins,
G protein-coupled receptors (GPCR) often display differ-
ent affinities for agonists at 378C. Determining the affinity
at that temperature is often difficult in intact cells as most
GPCRs are internalized after activation. When sequestra-
tion of the B2 bradykinin receptor (B2R) was inhibited by
either 0.5 M sucrose or phenylarsine oxide (PAO), a shift
in the affinity was detected when the incubation temper-
ature was raised from 48C to 378C or lowered from 378C
to 48C. In contrast, binding of the antagonist w3HxNPC
17731 was temperature-independent. B2R mutants dis-
played different affinity shifts allowing conclusions on the
role of the involved amino acids. By inhibiting receptor
sequestration it was possible to determine also dissoci-
ation of w3HxBK and of w3HxNPC 17731 from intact cells
at 378C. Surprisingly, both dissociation rates were mark-
edly enhanced by the addition of unlabeled ligand, most
likely via prevention of reassociation of dissociated
w3Hxligand. This suggests that dissociated w3Hxligand can-
not move freely away from the receptor.
In summary, our data demonstrate that inhibition of
receptor internalization either by PAO or sucrose pro-
vides an excellent method to study receptor function and
the effects of mutations in intact cells.
Keywords: G protein-coupled receptor; internalization;
kinin; NPXXY.
Introduction
The family of the G protein-coupled receptors (GPCRs)
represents one of the largest groups with more than a
thousand members identified in the mammalian genome
(Gether, 2000; Pierce et al., 2002). Their name derives
from their ability to recruit intracellular heterotrimeric G
proteins when stimulated by an extracellular agonist.
They play a pivotal role in the perception of the environ-
ment because light and odor are sensed in higher organ-
isms via members of this receptor family. They are also
involved in the control of physiology and behavior as
indicated by the immense chemical diversity of their
endogenous ligands. Therefore deeper insight into the
mechanisms by which these GPCRs are regulated and
how they mediate extracellular signals through the
membrane into the cell is of highest interest. Advanced
knowledge of the structure/function relationship of
GPCRs as well as of useful differences between the var-
ious family members is indispensable for the develop-
ment of better and more specific drugs to interfere with
their signal transduction.
One characteristic property of GPCRs is that most of
them respond in crude membrane preparations to the
addition of GTP at higher temperatures ()258C) with a
shift to lower affinity for agonists but usually not for
antagonists. The extent of the shift that can be observed
with different GPCRs varies markedly from no shift at all
(AT2 angiotensin receptor, Zhang and Pratt, 1996; B1 bra-
dykinin receptor, Faussner et al., 1999), to 3–10 fold
reductions for some peptide receptors (AT1 angiotensin
receptor, Hunyady et al., 1995; B2 bradykinin receptor,
Faussner et al., 1998) to 50–100 fold, e.g. for the A2A
adenosine (Murphree et al., 2002) or the b-adrenergic
receptor (Schwarz et al., 1986; Rasenick et al., 1994).
Despite this variance and sometimes even its absence,
this shift in response to GTP addition is considered a
landmark of GPCRs because according to the currently
accepted models of receptor regulation it reflects the
coupling to (high affinity state) or uncoupling from (low
affinity state) their cognate G protein(s). It has, however,
been reported that not only heterotrimeric G proteins but
also other intracellular proteins, e.g. small G proteins or
arrestins, can influence the affinity of a GPCR (Gurevich
et al., 1997; Mitchell et al., 1998).
In order to determine a shift in affinity usually (crude)
membrane preparations have to be prepared and the dis-
sociation constant Kd has to be determined with a radio-
labeled agonist in the presence or absence of GTP. In
many cases, the assay has to be conducted at temper-
atures lower than 378C, because otherwise no shift can
be detected. Alternatively, using a suitable radiolabeled
antagonist, a right-shift in the competition curves of the
unlabeled agonist after addition of GTP can indicate an
affinity shift. The latter is applicable mostly for receptors
that show a strong shift. The determination of the shift in
intact cells is in many cases hampered by the fact that
the majority of the GPCRs respond to agonist stimulation
with rapid sequestration of the receptors from the cell
surface (Koenig and Edwardson, 1997). Correct meas-
urement of the Kd is, therefore, impossible, as binding at
equilibrium is a prerequisite.
The B2 bradykinin receptor (B2R) belongs to the class
A, the rhodopsin/b2-adrenergic-like GPCRs (Fredriksson
et al., 2003), and mediates the effects of the hormones
bradykinin (BK) and kallidin (Regoli et al., 2001). These
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Figure 1 Binding reduction in the poorly internalizing B2R
mutant G327stop.
After preincubation with 2 nM w3HxBK for 90 min on ice, HEK 293
cells stably expressing the poorly internalizing B2R mutant
G327stop (A) or, for a comparison, the wild-type B2R (B) were
placed in a water bath at 378C. At the indicated times the
amounts of surface-bound (m) and internalized (d) w3HxBK were
determined as described in the materials and methods section.
The insets show the internalization as calculated in percentage
of total bound (h) w3HxBK (surface plus internalized). Values rep-
resent the mean"SD of triplicate determinations. One represen-
tative experiment out of three is shown.
short peptides (nine and ten amino acids, respectively)
are released from their high-molecular weight precursors,
the kininogens, through the action of specific enzymes,
the kallikreins (Clements et al., 2001). Stimulation of the
B2R results in vasodilatation, edema formation, and
induction of pain (Proud, 1988).
We have previously shown that the B2R in intact human
fibroblast as well as in crude membrane preparations
when kept 48C on ice is apparently in a high affinity state.
In crude membranes this high affinity state was also quite
stable at 378C, but could be reduced to lower affinity by
addition of GTP or GDP (Faussner and Roscher, 2000).
When we observed in intact cells that poorly internal-
izing B2R mutants (Faussner et al., 1998) still exhibited a
significant drop in surface binding activity when the tem-
perature was raised from 48C to 378C, we set out to
investigate whether this observation was caused by a
shift in the receptor affinity and if so, how this effect
could be used to study the binding behavior and signal-
ing of internalizing wild-type receptor and receptor
mutants in intact cells.
Results
Poorly internalizing B2R mutant displays decreased
binding activity at 378C
A B2R mutant (G327stop) lacking the C-terminal tail due
to insertion of a stop codon after glycine 327 (Faussner
et al., 1998) was preincubated at 48C with w3HxBK and
then warmed up to 378C in order to start ligand inter-
nalization. A clear reduction in surface binding was
observed that reached a plateau within 5 min. This reduc-
tion was seen despite the poor ligand internalization,
suggesting that this effect is unlikely caused by seques-
tration of the receptor. As the internalization rate is usu-
ally calculated as internalized w3Hxligand in percentage of
the combined amount of internalized and surface bound
w3Hxligand, a reduction in surface binding leads to an
apparently increased ligand internalization (inset Figure 1)
even when absolute ligand internalization (Figure 1) is
slow. This drop in total binding can of course be
observed only when the internalization process is started
at 378C after reaching the binding equilibrium at 48C, and
not when the w3Hxagonist is added directly at 378C. Sim-
ilar results were obtained with G327stop expressed in
Chinese hamster ovary cells, indicating that this effect
does not depend on the cell type.
Inhibition of receptor sequestration reveals reduced
surface binding also in wt B2R
Next we investigated whether the observed reduction in
surface binding is due to a loss in receptor number, i.e.
part of the receptors becoming inactive for binding, or
due to a defined shift of the receptor affinity occurring
when the incubation temperature is raised from 48C to
378C. Moreover, it should be clarified whether this reduc-
tion is a general property of the wt B2R or solely of the
mutant G327stop lacking the C-terminal domain. Due to
the fast internalization of the wt B2R reduction of surface
binding is generally considered to be a consequence of
receptor sequestration. An accompanying receptor inac-
tivation or affinity shift would be noticed only after inhi-
bition of the receptor internalization.
Therefore, we applied two common methods to pre-
vent B2R sequestration: firstly, the hyperosmolaric meth-
od with addition of 0.5 M sucrose in the incubation
medium (Heuser and Anderson, 1989) is supposed to
disrupt the clathrin-coat of certain vesicles, thereby
inhibiting receptor sequestration. This method, however,
may affect also receptor sequestration which does not
involve clathrin-coated pits via so far unknown mecha-
nisms (Roseberry and Hosey, 2001).
Secondly, we used preincubation of the cells for 5 min
at 378C with 100 mM phenylarsine oxide (PAO; Hertel et
al., 1985).
Both treatments effectively prevented the internaliza-
tion of w3HxBK (Figure 2A, B) by the wt B2R. Less than
20% (0.5 M sucrose, Figure 2A) and even less than 10%
(100 mM PAO, Figure 2B) of totally bound w3HxBK became
internalized after 30 min at 378C. However, despite this
inhibition of ligand internalization, a reduction in surface
binding was observed with both treatments resulting in a
plateau after 5–10 min. Because the PAO preincubation
evoked a stronger inhibition and is easier to perform, it
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Figure 2 Inhibition of w3HxBK internalization by sucrose and
PAO.
HEK 293 cells with high expression of B2Rs w10.4 pmol/mg pro-
tein; B2R(high)x were either incubated on ice for 90 min with
w3HxBK in the presence of 0.5 M sucrose (panel A) or after pre-
treatment with PAO (panel B). Subsequently the cells were trans-
ferred to a water bath at 378C. The concentration of w3HxBK was
12 nM and 13.4 nM, respectively. At the indicated times the
amount of internalized and surface-bound w3HxBK was deter-
mined as described in the materials and methods section. The
determinations were performed in triplicates and are given as
mean"SD. Each experiment was conducted at least three times
with similar results.
Figure 3 Equilibrium binding curves at 48C or at 378C, respec-
tively, and after change of temperature.
(A) HEK 293 cells expressing B2R(high) were incubated with
increasing concentrations of w3HxBK (0.03–30 nM) for 90 min on
ice with (s) and without (d) additional incubation for 30 min at
378C. Thereafter, specific binding was measured as described
in ‘materials and methods’. Each point represents the mean of
duplicate determinations. Regression analysis of the data gave
the equilibrium constants Kds3.0"0.34 nM (48C) and Kds8.2
0.12 nM (48C™378C).
(B) HEK 293 cells expressing B2Receptors w4.4 pmol/mg protein;
B2R(low)x were incubated with increasing concentrations of
w3HxBK at 378C with (s) or without (n) by an additional incuba-
tion on ice for 90 min. Control cells (d) were incubated on ice
only. Each value is the mean of duplicates. Regression analysis
resulted in the following equilibrium constants Kds2.8"0.17 nM
(378C), 9.7"0.15 nM (378C™48C), and 3.5"0.18 nM (48C). Each
experiment was repeated at least twice with similar results.
became our preferred method for inhibiting receptor
sequestration. Other (pre)treatments of the cells either
with N-methyl-maleimide (1 mM, 5 min/378C) or digitonin
(20 mg/ml, 5 min/378C) also strongly inhibited ligand
internalization of the wt B2R and resulted in identically
reduced binding activity at 378C.
Reduction of surface binding at 378C is due to a
reversible shift in affinity
Equilibrium binding and subsequent Scatchard analysis
of the data revealed that the binding reduction as a con-
sequence of the raise of the incubation temperature from
48C to 378C is not due to a loss of receptors, but is rather
caused by a shift in the receptor affinity for w3HxBK (Figure
3A). This shift is not an artifact provoked by increased
w3HxBK degradation at 378C, because it can also be
observed in the reverse direction: while the binding
curves of cells incubated at 378C indicate a lower recep-
tor affinity (Figure 3B), the binding curves become almost
identical after an additional incubation on ice to those of
cells that have been placed on ice immediately. The
receptor affinity at 48C after PAO pre-treatment was iden-
tical to that of control cells which were not treated with
PAO (not shown), suggesting that PAO does not affect
those parts of the receptor that are directly involved in
ligand binding. The temperature change influenced only
the binding of the agonist w3HxBK, but not that of the
antagonist w3HxNPC 17731 (cf. Figure 5B).
Different affinity shifts occur in wt B2R and receptor
mutants
Next we wanted to compare the temperature-induced
affinity shifts of wt B2Rs with high (10.4 pmol/mg protein)
and lower (4.4 pmol/mg protein) expression with that of
different receptor mutants (see Table 1). One of these
mutants was the construct Y305A, in which the tyrosine
in the highly conserved NPXXY sequence located at the
end of the 7th transmembrane segment was exchanged
by an alanine. This mutant was of particular interest,
because we had shown recently that it is precoupled to
G protein Gq/11 even in the absence of an agonist (Kalats-
kaya et al., 2004). A reason for this behavior might be
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Table 1 Expression levels (Bmax) and dissociation constants (Kd) of wild-type and
mutant B2 receptors at 48C and at 378C.
Construct Bmax (pmol/mg protein) Dissociation constant Kd (nM)
48C 378C
B2R (high) 10.4 4.71"0.99 (3) 11.77"2.77 (3)
B2R (low) 4.4 1.99"0.28 (4) 7.56"1.28 (4)
Y305A 2.1 2.82"0.58 (5) 1.65"0.24 (5)
E177A 7.9 23.28"1.05(3) )200 (3)
E177A/Y305A 3.2 9.64"0.55 (7) 58.23"8.44 (7)
Receptor constructs were stably expressed in HEK 293 cells. Maximal binding
capacity Bmax was estimated with 40 nM w3HxBK at 48C. The values for the dis-
sociation constant Kd at 48C and at 378C were determined as described in the
materials and methods section and are given as mean"SEM. The number of
experiments is indicated in parentheses.
Figure 4 Temperature dependence of ligand binding by wt
B2Rs(high/low) or by the receptor mutants Y305A and E177A.
PAO-pretreated cells expressing the indicated receptor con-
structs were incubated on ice with 1.3 nM w3HxBK for at least
60 min. Subsequently, cells were warmed up to the indicated
temperatures (168C, 208C, 258C, 308C, 378C) or kept further on
ice. Specific binding was determined after 30 min as described
in ‘materials and methods’. The results are given as mean"SD
from a representative experiment performed in triplicate and
expressed in percentage of the binding at 48C. For each con-
struct the experiment was repeated at least two times in inde-
pendent experiments with similar results. (d) wt B2R(high), (s)
wt B2R(low), (n) Y305A, (m) E177A.
that Y305A displays a persistent high affinity conforma-
tion. The second mutant, termed E177A, was of interest
as the mutated glutamate at position 177 should play a
role in high affinity binding of w3HxBK (Kyle et al., 1994;
Jarnagin et al., 1996). The third construct carried both
mutations (mutant E177A/Y305A).
The high and low expressed B2Rs exhibited a slightly
different affinity, however, in both cases a clear temper-
ature-dependent shift was obvious (see Table 1). In con-
trast, mutant Y305A revealed a tendency to higher affinity
at 378C instead of exhibiting a shift to lower affinity. This
result suggests that the mutation of the tyrosine in the
NPXXY sequence indeed induces a receptor conforma-
tion that permanently displays a high affinity.
Mutant E177A displayed a complete different behavior
than construct Y305A. Already at 48C its affinity was
approximately 6 times lower than that of the wt B2Rs
suggesting that glutamate 177 is directly involved in
binding. At 378C its affinity was reduced to such an
extent that it could only be estimated as being)200 nM
under the assumption that the reduction in binding was
not due to a loss in receptors. That this assumption is
justified was indicated by the fact that the high affinity
binding could almost completely be recovered by a sub-
sequent incubation on ice (not shown), similarly as dem-
onstrated before for the wt B2R (cf. Figure 3). This strong
affinity shift might be a combination of two independent
effects, the reduced binding affinity caused by changing
an amino acid involved in ligand binding and the affinity
reduction due to a conformational change induced by
activation of the receptor mutant. This notion is support-
ed by the affinity shift observed for the double mutant
E177A/Y305A that also exhibited a reduced affinity at
48C as compared to the wt B2Rs, but a distinctly lesser
reduced affinity at 378C (cf. Table 1). This was most likely
because the reduction component caused by the con-
formational change is blocked by the second mutation
of tyrosine Y305 to alanine. These results suggest that
glutamate 177 is important solely for high affinity binding
of BK but is not directly involved in the activation of the
B2 receptor.
Temperature dependence of the affinity shift varies
in wt B2R and the selected mutants
We next investigated the behavior of these receptor con-
structs by taking a closer look at the temperature-
dependence of their ligand binding (Figure 4). For this
purpose the different cell clones were pre-equilibrated
with w3HxBK at concentrations below their Kd and then
warmed up to the indicated temperatures. Mutant E177A
showed an almost linear inverse correlation between
increased temperature and reduction of binding, whereas
both wt B2Rs responded only at temperatures above
258C with a strong decrease in binding. Construct Y305A
displayed no reduction at all, but rather a maximum of
binding at temperatures between 208C and 308C.
Fast dissociation at 378C requires addition of
unlabeled BK or antagonist JE049
Besides the measurement of equilibrium dissociation
constants at 378C, the inhibition of receptor sequestra-
tion also allowed the determination of the dissociation
rate of w3Hxlabeled agonist (w3HxBK) or antagonist
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Figure 5 Dissociation of the agonist w3HxBK and the antagonist
w3HxNPC 17731 from PAO treated cells.
PAO treated HEK 293 cells expressing wt B2R(high) were incu-
bated on ice for 90 min with 3 nM w3HxBK or 16 nM w3HxNPC
17731. Subsequently, either 1 mM unlabeled BK was added and
the cells placed at 378C (d) or the cells were washed on ice to
remove unbound w3Hxligand and the dissociation was started by
adding 378C warm buffer with (m) or without (n) addition of 1mM
BK. At the indicated times the remaining surface binding was
determined as described in the materials and methods section.
For comparison data from cells without washing and addition of
unlabeled BK (s) are shown. The values represent the mean"SD
of triplicate determinations.
Figure 6 Dissociation of w3HxBK with increased receptor
occupancy.
PAO-pretreated HEK 293 cells expressing B2R(high), were prein-
cubated with 1.2 nM w3HxBK for 90 min on ice. Thereafter the
indicated amounts of unlabeled agonist BK or antagonist JE049
were added for another 10 min on ice. The cells were washed
to remove unbound labeled as well as unlabeled ligand and the
dissociation was started by adding warm buffer and placing the
cells in a water bath at 378C. For a comparison also the disso-
ciation in the continued presence of 1 mM BK was performed
(m). Remaining surface binding was determined at the indicated
times as described in ‘materials and methods’. Values are given
as the mean"SD of triplicate determinations. A second experi-
ment was performed with similar results.
(w3HxNPC 17731) at 378C from cell surface receptors in
intact cells. The experiments were performed in two
ways: after preincubation of PAO treated cells at 48C with
w3Hxligand (agonist or antagonist), dissociation was start-
ed either by directly adding 1 mM unlabeled BK – in order
to prevent reassociation of dissociated w3Hxligand – and
placing the trays in a water bath at 378C. Alternatively,
unbound w3Hxligand was first removed by washing the
cells at 48C and then the dissociation was started by
addition of warm incubation buffer (378C) with or without
addition of 1 mM unlabeled BK. At the indicated times
remaining surface binding was determined by acetic acid
treatment.
Quite surprisingly, a large difference in the dissociation
rate of w3Hxligand became obvious depending on whether
a high surplus of unlabeled BK was added or not. In the
presence of 1 mM unlabeled BK (or of the antagonist
JE049, data not shown) there was a rapid dissociation of
the agonist w3HxBK as well as of the antagonist w3HxNPC
17731 (Figure 5A, B). The dissociation did not depend on
whether unbound w3Hxligand had been removed before
by washing the cells or the incubation was continued in
its presence. In the absence of unlabeled BK, however,
the dissociation rate of w3HxBK was much slower and did
not exceed significantly the rate that was caused by the
drop in affinity (Figure 5A). The same effect was observed
for the antagonist w3HxNPC 17731, yet with the difference
that there was no change in binding when the cells were
incubated at 378C in the continued presence of w3HxNPC
17731 (Figure 5B), demonstrating that the receptor affin-
ity for the antagonist is clearly temperature-independent.
Effect of unlabeled ligand is probably due to
prevention of reassociation of dissociated w3Hxligand
In Chinese hamster ovary (CHO) cells expressing high
levels of B2R a negative cooperativity of the receptors
resulting in faster dissociation rates with higher receptor
occupancy has been reported (Pizard et al., 1998). In
order to differentiate between a fast dissociation rate
caused by a negative cooperativity effect and one result-
ing from inhibition of rebinding of dissociated w3Hxligand,
PAO-treated HEK 293 cells expressing the wt B2R(high)
were incubated with 1 nM w3HxBK (a concentration below
the Kd at 48C) on ice, leading to occupation of less than
half of all B2 receptors. Subsequently, unbound w3HxBK
was removed by a brief wash with buffer at 48C and the
cells were further incubated with increasing amounts of
unlabeled BK up to 1 mM for another 10 min on ice. This
procedure should have resulted in increased receptor
occupancy with full occupancy at the highest concentra-
tions of unlabeled BK and at the same time almost iden-
tical binding of w3HxBK due to the very slow off-rate of
w3HxBK at 48C. When these cells were placed at 378C,
dissociation of w3HxBK was indeed more rapid with higher
receptor occupancy. However, the maximal rates were
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Figure 7 Dissociation rates of different receptor constructs.
PAO treated HEK 293 cells expressing the indicated constructs
were preincubated on ice with approximately 4 nM w3HxBK for
90 min to reach equilibrium. Subsequently, the cells were
washed with ice-cold PBS and placed in a water bath at 378C
after addition of 1 mM BK in incubation buffer (378C). At the
indicated times dissociation was stopped by washing the cells
with ice-cold PBS and remaining surface binding was deter-
mined as described in the materials and methods section. Data
are expressed as percentage of initial binding on ice and rep-
resent the mean"SEM from at least 3 independent experiments
performed in duplicate. Abbreviations: wt B2R: wild-type B2 bra-
dykinin receptor; Y305A: B2 bradykinin receptor mutant with a
Tyr™Ala exchange at position 305; E177A: receptor mutant with
a Glu™Ala exchange at position 177; E177A/Y305A: receptor
double mutant with both amino acid exchanges.
still far slower than the rate reached in the continued
presence of 1 mM unlabeled BK (Figure 6). These data
suggest that prevention of reassociation of w3HxBK plays
an important role in the fast dissociation observed in the
presence of unlabeled BK. This notion was further sup-
ported by the fact that the dissociation rate enhancing
effect was not specific for the agonist BK but was also
found with the antagonist JE049 (Figure 5).
w3HxBK dissociation rates of receptor constructs
reflect their Kd at 378C
Determination of the dissociation constants Kd (see
above) yields information on the system under equilibri-
um conditions but does not provide information on the
kinetics of ligand association or dissociation. Therefore,
we also determined the dissociation rates (in the pres-
ence of 1 mM BK) of the before mentioned mutants.
There was no difference in the dissociation rates between
the high and the lower expressing B2R. They are therefore
included as one construct in Figure 7, and displayed a
reduction of binding to approx. 25% of initial values on
ice within 2 min at 378C. Mutant E177A dropped to 10%
in less than a minute, whereas mutant Y305A revealed a
very slow off-rate displaying approx. 75% of the initial
binding after 2 min. The double mutant E177A/Y305A
showed a dissociation rate slower than E177A but dis-
tinctly faster than the wt B2R. Thus, the dissociation rates
reflected well the different equilibrium affinities deter-
mined at 378C after 30 min (cf. Table 1) and could be
used to obtain a first estimate of the affinities of a recep-
tor construct at 378C.
Discussion
One of the hallmarks of G protein-coupled receptors is
the shift to lower affinity for agonists when guanine
nucleotides such as GDP or GTP, or their poorly hydro-
lysable derivatives such as GTPgS, are added to
membrane preparations at higher temperatures (Milligan,
2003). In the ternary complex model the high affinity state
represents the receptor in its active conformation stabi-
lized by binding to the G protein, whereas the low affinity
state represents the uncoupled receptor (Gether, 2000).
In the absence of guanine nucleotides, the ternary com-
plex composed of agonist, G protein, and the receptor
exhibiting high affinity is stable and dissociates only after
addition of guanine nucleotides.
Despite being a hallmark of GPCRs the extent of the
affinity shift can vary strongly from receptor to receptor.
Whereas, for example, addition of guanine nucleotides to
the b2-adrenergic receptor leads to a shift from 1.91=10-
9 to 1.8=10-5 M, i.e. a shift of almost four orders of mag-
nitude (Rasenick et al., 1994), the B2R in crude
membrane preparations of human foreskin fibroblasts
exhibited only a shift from approximately 2 to 14 nM
(Faussner and Roscher, 2000). Moreover, in the AT2 angi-
otensin receptor no shift at all is observed (Zhang and
Pratt, 1996). In this respect it has to be mentioned that
also interactions with other cytosolic proteins, such as
arrestins or small G proteins, have been reported to result
in high affinity binding of receptors (Gurevich et al., 1997;
Mitchell et al., 1998).
In receptors that exhibit a large affinity shift this effect
can be measured in competition experiments allowing a
radioactive labeled antagonist to compete with increas-
ing concentrations of unlabeled agonist. Addition of GTP
then leads to a shift in the agonist displacement curve to
the right side indicating the reduction in receptor affinity.
For other receptors, such as the B2R, a right-hand shift
in the order of one magnitude would be difficult to deter-
mine and would require a radiolabeled high affinity antag-
onist. The latter, however, is currently not commercially
available for the B2R. In such a case, it is more conven-
ient to measure the different affinities of the receptor for
a radioactive agonist in the presence and absence of
guanine nucleotides directly in crude membrane fractions
at higher temperatures. However, especially with lysates
of cells overexpressing the B2R, we found often a reduc-
tion in the affinity of the receptor when the temperature
was raised from 48C to 378C. This effect was independ-
ent of an addition of exogenous GTP, thus reducing the
measurable change (not shown). A reason for this behav-
ior could be that due to the overexpression of the recep-
tors not all receptors are coupled to a G protein and,
therefore, can bind only with low affinity at 378C. Since
the B2R on ice always exhibited only one binding site with
high affinity this would suggest that coupling to a G pro-
tein is not required for high affinity binding at 48C. At this
low temperature, weak interactions between side chains
of the receptor and/or with membrane lipids might be
strong enough to stabilize a conformation which may be
maintained at 378C only by coupling to a G protein or
other cytosolic proteins. If this hypothesis holds true,
then the conformation of the receptors on ice, in partic-
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ular the conformation of its binding site, should be iden-
tical or very similar to the conformation of the coupled
receptor at 378C. This hypothesis is strengthened by the
reversibility of the shift through an additional incubation
on ice. At this low temperature it is unlikely that the high
affinity binding state is obtained by the receptor via
recoupling to or recruiting of a G protein or other signal-
ing proteins. However, the possibility cannot be excluded
that the receptor – similar to its ability to bind extracel-
lularly an agonist at 48C – is capable of interacting intra-
cellularly with proteins at low temperatures. Further
studies are therefore required to reach a final conclusion
on this matter. The GTP-independent affinity reduction in
membrane preparations at higher temperatures seems to
be a common phenomenon of GPCRs, since most
assays for a GTP effect on receptor affinity are conduct-
ed at temperatures below the physiological temperature
of 378C, i.e. at 258C or 308C.
There was no significant difference between the Kd val-
ues of B2R and mutant Y305A at 48C, although we have
shown recently that the latter is precoupled to G protein
Gq/11 even in the absence of an agonist (Kalatskaya et al.,
2004). The high affinity of this mutant at 378C could at
first sight be explained as a consequence of this
increased coupling to Gq/11. Mutant Y305A is, however,
able to stimulate inositol phosphate accumulation even
better than the wt B2R (Kalatskaya et al., 2004), and
therefore also should repeatedly uncouple from Gq/11. For
this reason it seems that this mutation results in a recep-
tor conformation that is not only able to couple to Gq/11
in the absence of an agonists but also persistently dis-
plays the high affinity binding that in the wt B2R would
be induced only by the coupling to a G protein. Thus,
this mutant apparently combines a propensity to pre-
couple to Gq/11 with permanent high affinity for the ago-
nist BK.
By inhibiting receptor sequestration either through the
use of a hyperosmolaric incubation buffer (0.5 M sucrose)
or pretreating the cells with 100 mM PAO, we were able
to measure a temperature-dependent shift in the receptor
affinity in intact cells with good reproducibility. Phenylar-
sine oxide (PAO) acts on proteins by bridging vicinal sulf-
hydryl (SH)-groups of cysteins (Rokutan et al., 2000). The
bridging, however, is not required for inhibition of B2R
internalization since monovalent N-methyl-maleimide
could also block w3HxBK internalization. Because PAO
does not change the affinity of the receptor at 48C, there
should be no direct modification of the ligand binding site
or the receptor. Furthermore, a cell impermeable SH-
group-modifying reagent (monobromotrimethyl-ammo-
niobimane bromide; de Lamirande and Gagnon, 1998)
was not able to block receptor sequestration (not shown)
suggesting that the SH-groups which must be modified
for inhibition of receptor internalization are located inside
the cell. Although PAO is often applied as a nonspecific
tyrosine phosphatase inhibitor (Fletcher et al., 1993;
Yingst et al., 2000), the concentrations used for this pur-
pose (-25 mM) were not sufficient to inhibit B2R inter-
nalization. For this reason it is unlikely that tyrosine
phosphatases play a role in the prevention of receptor
sequestration by PAO. The fact that besides treatment
with PAO and 0.5 M sucrose also pretreatment with digi-
tonin or N-methyl maleimide allowed the determination
of the temperature-dependent affinity shift with similar
results indicates that this shift is independent of the
method used for inhibition of receptor sequestration and,
therefore, represents an intrinsic property of the receptor
itself.
The presented data suggest that the shift in the affinity
of the B2R for w3HxBK is not caused by unspecific phys-
ical effects of the raise in incubation temperature, such
as increased membrane fluidity, but involves the activa-
tion of the receptor by an agonist at temperatures higher
than 208C (cf. Figure 4). The affinity shift is also not cell
type dependent, since it was also observed in CHO cells
heterologously expressing the human B2R, as well as in
human fibroblasts or in human embryonic lung fibro-
blasts WI-38 expressing naive B2 kinin receptors (un
published results). In addition, for the a1-adrenergic
receptor it has been shown that the magnitude of a sim-
ilar temperature shift determined in membranes for sev-
eral (partial) agonists correlates well with their functional
efficacy (Weiland et al., 1979).
Moreover, we could show that the presence of a sur-
plus of an unlabeled ligand is necessary for fast disso-
ciation of a bound w3Hxligand (cf. Figures 5 and 6). Since
this is similar for agonists and antagonist and works
despite inhibition of receptor sequestration, the most
likely explanation for this phenomenon is as follows: the
receptors can still move into some half-closed compart-
ments on the cell surface, where dissociated w3Hxligand
remains close to the receptor and unlabeled ligand is
necessary to prevent its reassociation. This behavior
would be similar to that observed for the B1 bradykinin
receptor, which is not internalized after activation but
translocates within in the plasma membrane to caveolae-
related rafts on the cell surface (Sabourin et al., 2002).
In summary, using the B2 bradykinin receptor as a
model we have demonstrated in this report how inhibition
of receptor sequestration by either 100 mM PAO or 0.5 M
sucrose can be used to determine in intact cells the tem-
perature-dependent affinity shift and ligand dissociation
rates of G protein-coupled receptors or mutants thereof,
thus providing information on the functional role of amino
acids and domains in these receptors.
Materials and methods
Materials
Flp-In TREx-293 (HEK 293) cells were bought from Invitrogen
(Groningen, Netherlands). w2,3-prolyl-3,4-3Hxbradykinin (90 Ci/
mmol) and wprolyl-3,4-3HxNPC17731 (48.5 Ci/mmol, no longer
commercially available) were obtained from Perkin Elmer Life
Sciences (Boston, USA). Bradykinin was purchased from
Bachem (Heidelberg, Germany). The antagonist JE049 (formerly
known as Hoe 140/Icatibant) was a generous gift from Jerini AG
(Berlin, Germany). Roche (Mannheim, Germany) delivered
Fugene. Poly-D-lysine hydrobromide, captopril, 1.10-phenan-
throline, and bacitracin were purchased from Aldrich (Taufkir-
chen, Germany). Fetal calf serum, culture media, hygromycin B,
and penicillin/streptomycin were delivered by PAA Laboratories
(Co¨lbe, Germany).
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Expression system and cell culture
The Flp-In system from Invitrogen was used to generate stable
clones expressing the wt B2R, the receptor truncation G327stop
(stop codon after glycine 327; Faussner et al., 1998) and the
point mutants Y305A (Kalatskaya et al., 2004) and E177A. All
sequences started with the third encoded methionine (Hess et
al., 1992) and were cloned into the HindIII and the XhoI sites of
the pcDNA5/FRT vector. The receptor sequences were preceded
at the N-terminus by a hemagglutinin-tag (MGYPYDVPDYAGS),
with the last two amino acids (Gly-Ser) of the tag being created
by the insertion of a BamHI site. Flp-In TREx-293 (HEK 293) cells
were transfected with Fugene (Roche) following the instructions
of the manufacturer w2 mg plasmid(s) plus 5 ml Fugene per
6-well dishx. Single stably transfected clones were obtained after
selection with 250 mg/ml hygromycin B. Clones exhibiting sim-
ilar high binding activities were considered to represent a single
insertion of the pCDNA5/FRT vector (containing the receptor
gene) at the recombinase target site (usually at least 3 out of 6
clones). Cells with twice as much binding activity were pre-
sumed to have an additional insertion of the vector (rare), clones
with less binding activity were supposed to be inhomogeneous
and, therefore, not further propagated. HEK 293 cells were cul-
tivated in DMEM supplemented with 10% fetal calf serum and
penicillin/streptomycin. For experiments requiring rinsing of the
cells poly-D-lysine-treated multi-well plates were used.
Internalization of w3HxBK
Monolayers on multi-well trays were rinsed with phosphate-buf-
fered saline (PBS) and incubated with w3HxBK in incubation buffer
(40 mM PIPES, 109 mM NaCl, 5 mM KCl, 0.1% glucose, 0.05%
BSA, 2 mM CaCl2, 1 mM MgCl2, pH 7.4 containing the degra-
dation inhibitors: 2 mM bacitracin, 0.8 mM 1.10-phenanthroline,
and 100 mM captopril) for 90 min on ice in order to obtain equi-
librium binding (Faussner et al., 2003). Internalization of w3HxBK
was started by warming the plates to 378C in a water bath and
was terminated at the indicated times by placing the plates on
ice and washing the cells four times with ice-cold PBS. There-
after, surface-bound w3HxBK was dissociated with 0.2 ml of an
ice-cold dissociation solution (0.2 M acetic acid/0.5 M NaCl,
pH 2.7) for 10 min on ice. The supernatant was quantitatively
transferred to a scintillation vial by rinsing the cells with another
0.2 ml of PBS. The remaining cell monolayer, containing the
internalized w3HxBK, was lysed using 0.2 ml 0.3 M NaOH and
transferred with another 0.2 ml water to a scintillation vial. The
amount of tritium in both samples was measured in a b-counter
after addition of scintillation fluid. Nonspecific w3HxBK internali-
zation and surface binding were determined in the presence of
3 mM unlabeled BK and subtracted from total binding to obtain
specific values. Internalization was expressed as the amount of
internalized w3HxBK in percentage of the combined amount of
internalized and surface bound w3HxBK.
w3HxBK binding studies
For the determination of the dissociation constant Kd and recep-
tor number Bmax at 48C and in particular at 378C, receptor
sequestration was inhibited by pretreatment of the cells with
100 mM phenylarsine oxide (PAO, 10 mM stock solution in
DMSO) in incubation buffer without inhibitors for 5 min at 378C.
Alternatively, receptor sequestration was blocked by the contin-
ued presence of 0.5 M sucrose in the incubation buffer.
Confluent monolayers on 24-well/48-well trays with or without
PAO treatment were rinsed three times with PBS and incubated
with 0.3/0.2 ml of ice-cold incubation buffer containing increas-
ing concentrations of w3HxBK (10 concentrations ranging from
approx. 0.01 nM to 30 nM) for at least 90 min on ice. For the
determination of values at 48C the incubation was stopped by
rinsing the cells four times with ice-cold PBS. The cells were
then lysed in 0.2 ml 0.3 M NaOH and transferred to a scintillation
vial. For determination of the Kd at 378C, the cells were first
incubated for 90 min on ice and then warmed up in a water bath
at 378C. After 30 min the monolayers were washed with ice-cold
PBS and w3HxBK binding determined as described before.
For the incubation at 378C with or without a second incubation
at 48C, the radioactive solutions were added quickly on ice and
the trays then immediately placed in the water bath at 378C.
After 30 min the incubation was either stopped as described
above (378C) or continued on ice (378C™48C) for 90 min. Deter-
mination of w3HxBK binding activity was then performed as
described above. Nonspecific binding (usually less than 5% of
total binding) was determined in the presence of 3 mM of unla-
beled BK and subtracted from total binding determined with
w3HxBK alone to calculate specific binding.
Protein determination
Protein concentrations were quantified with the Micro BCA Pro-
tein assay reagent kit from Pierce (Rockford, USA) using bovine
serum albumin as standard.
Data analysis
All data analysis was performed using GraphPad Prism for Mac-
intosh, Version 3.0a (GraphPad Software, Inc.).
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